Home
About
Team
JOTROL™
JOTROL™ Pre-Clinical Studies
Pipeline
Friedreich's Ataxia (JOT101)
>
JOT101 Project Advisors
Alzheimer's Disease (JOT108)
Partners
News
Contact
Investors
Resveratrol science
Policies
Menu
Home
About
Team
JOTROL™
JOTROL™ Pre-Clinical Studies
Pipeline
Friedreich's Ataxia (JOT101)
>
JOT101 Project Advisors
Alzheimer's Disease (JOT108)
Partners
News
Contact
Investors
Resveratrol science
Policies
JOT
ROL
™
Pre-Clinical Studies
JOT
ROL
™ significantly increases
bioavailability and absorption of resveratrol, and is expected to generate therapeutic effects at a lower dosage without GI side effects!
Home
About
Team
JOTROL™
JOTROL™ Pre-Clinical Studies
Pipeline
Friedreich's Ataxia (JOT101)
>
JOT101 Project Advisors
Alzheimer's Disease (JOT108)
Partners
News
Contact
Investors
Resveratrol science
Policies